A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
Conditions
Hypothalamic Obesity · Prader-Willi Syndrome · PWS
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UAB Pediatric Endocrinology (Part C and Part D), Birmingham, Alabama, United States
Ann and Robert H. Lurie Children's Hospital of Chicago (Part C and Part D), Chicago, Illinois, United States
Boston Children's Hospital (Part C only), Boston, Massachusetts, United States
Brigham and Women's Hospital (Part C and Part D), Boston, Massachusetts, United States
Vanderbilt University Medical Center (Part C only), Nashville, Tennessee, United States
Worldwide Clinical Trials (Part A and Part B), San Antonio, Texas, United States
University of Utah Pediatric Endocrine Clinic (Part C and Part D), Salt Lake City, Utah, United States
Study leads
David Meeker
Study Chair
Rhythm Pharmaceuticals, Inc.